HK1140939A1 - Tapentadol for treating pain from arthritis (tapentadol) - Google Patents

Tapentadol for treating pain from arthritis (tapentadol)

Info

Publication number
HK1140939A1
HK1140939A1 HK10107328.6A HK10107328A HK1140939A1 HK 1140939 A1 HK1140939 A1 HK 1140939A1 HK 10107328 A HK10107328 A HK 10107328A HK 1140939 A1 HK1140939 A1 HK 1140939A1
Authority
HK
Hong Kong
Prior art keywords
tapentadol
arthritis
treating pain
pain
treating
Prior art date
Application number
HK10107328.6A
Other languages
English (en)
Chinese (zh)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39500012&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1140939(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of HK1140939A1 publication Critical patent/HK1140939A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK10107328.6A 2007-04-23 2010-08-02 Tapentadol for treating pain from arthritis (tapentadol) HK1140939A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007019417A DE102007019417A1 (de) 2007-04-23 2007-04-23 Tapentadol zur Schmerzbehandlung bei Arthrose
PCT/EP2008/003177 WO2008128739A1 (de) 2007-04-23 2008-04-21 Tapentadol zur schmerzbehandlung bei arthrose

Publications (1)

Publication Number Publication Date
HK1140939A1 true HK1140939A1 (en) 2010-10-29

Family

ID=39500012

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10107328.6A HK1140939A1 (en) 2007-04-23 2010-08-02 Tapentadol for treating pain from arthritis (tapentadol)
HK15103768.7A HK1203160A1 (en) 2007-04-23 2010-08-02 Tapentadol for the treatment of pain in arthrosis (tapentadol)

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15103768.7A HK1203160A1 (en) 2007-04-23 2010-08-02 Tapentadol for the treatment of pain in arthrosis (tapentadol)

Country Status (22)

Country Link
US (3) US20090005458A1 (pl)
EP (3) EP2857013A1 (pl)
JP (1) JP5796959B2 (pl)
KR (4) KR20150027307A (pl)
CN (2) CN103298463A (pl)
AU (1) AU2008241012B2 (pl)
CA (1) CA2683779C (pl)
CY (1) CY1115975T1 (pl)
DE (1) DE102007019417A1 (pl)
DK (1) DK2148669T3 (pl)
ES (1) ES2528215T3 (pl)
HK (2) HK1140939A1 (pl)
HR (1) HRP20141234T1 (pl)
IL (1) IL201664A (pl)
MX (1) MX2009011346A (pl)
NZ (1) NZ580414A (pl)
PL (1) PL2148669T3 (pl)
PT (1) PT2148669E (pl)
RU (1) RU2473337C2 (pl)
SI (1) SI2148669T1 (pl)
WO (1) WO2008128739A1 (pl)
ZA (1) ZA200907356B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
CN104257600A (zh) * 2008-10-30 2015-01-07 格吕伦塔尔有限公司 新型有效的他喷他多剂型
AR074825A1 (es) * 2008-12-22 2011-02-16 Novartis Ag Regimen de dosificacion de un agonista de los receptores de s1p, metodo de tratamiento y kit
PT2424514T (pt) * 2009-04-30 2017-05-30 Gruenenthal Gmbh Tapentadol para o tratamento da dor artrítica reumatoide
WO2011133178A1 (en) * 2010-04-21 2011-10-27 Pharmacofore, Inc Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug
PT3656765T (pt) 2010-07-23 2021-05-25 Gruenenthal Gmbh Sais ou cocristais de 3-(3-dimetilamino-1-etil-2- metilpropil)fenol
CZ304576B6 (cs) * 2012-07-24 2014-07-16 Zentiva, K.S. Oxalát TAPENTADOLU a způsob jeho přípravy
US20180042895A1 (en) 2015-02-26 2018-02-15 Novartis Ag Treatment of autoimmune disease in a patient receiving additionally a beta-blocker
HUE054338T2 (hu) 2015-11-17 2021-08-30 Msn Laboratories Private Ltd Tapentadol sók kristályos formái és eljárás azok elõállítására
KR20210039706A (ko) 2019-10-02 2021-04-12 주식회사 엘지화학 병렬 연결 셀의 연결 고장 검출 방법 및 시스템
LT3995135T (lt) 2020-11-10 2022-08-25 Grünenthal GmbH Tapentadolio l-(+)-vyno rūgščių druskos pailginto atpalaidavimo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716646A (en) * 1990-05-01 1998-02-10 Smith; Steven A. Methods and compositions for treating arthritis
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
US20050005870A1 (en) 2003-07-11 2005-01-13 The Clorox Company Composite absorbent particles
ES2291780T3 (es) * 2004-06-28 2008-03-01 Grunenthal Gmbh Formas cristalinas del clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)fenol.
WO2007005716A2 (en) * 2005-06-30 2007-01-11 Cinergen, Llc Methods of treatment and compositions for use thereof

Also Published As

Publication number Publication date
NZ580414A (en) 2012-03-30
WO2008128739A1 (de) 2008-10-30
DE102007019417A1 (de) 2008-11-13
DK2148669T3 (en) 2015-01-05
KR20150027307A (ko) 2015-03-11
CN106619589A (zh) 2017-05-10
AU2008241012A1 (en) 2008-10-30
US20090005458A1 (en) 2009-01-01
MX2009011346A (es) 2009-11-05
ZA200907356B (en) 2010-08-25
EP2857013A1 (de) 2015-04-08
HRP20141234T1 (hr) 2015-02-27
KR20100017268A (ko) 2010-02-16
HK1203160A1 (en) 2015-10-23
AU2008241012B2 (en) 2012-12-06
EP2148669B1 (de) 2014-12-10
CY1115975T1 (el) 2017-01-25
CN103298463A (zh) 2013-09-11
EP3673903A1 (de) 2020-07-01
US20100331425A1 (en) 2010-12-30
IL201664A0 (en) 2010-05-31
SI2148669T1 (sl) 2015-01-30
KR20190020849A (ko) 2019-03-04
EP2148669A1 (de) 2010-02-03
RU2009142937A (ru) 2011-05-27
JP2010524989A (ja) 2010-07-22
PT2148669E (pt) 2015-02-03
IL201664A (en) 2016-11-30
ES2528215T3 (es) 2015-02-05
PL2148669T3 (pl) 2015-03-31
CA2683779A1 (en) 2008-10-30
CA2683779C (en) 2016-01-05
RU2473337C2 (ru) 2013-01-27
US20120041071A1 (en) 2012-02-16
JP5796959B2 (ja) 2015-10-21
KR20170068608A (ko) 2017-06-19

Similar Documents

Publication Publication Date Title
HK1140939A1 (en) Tapentadol for treating pain from arthritis (tapentadol)
EP2124778A4 (en) DEVICES FOR TREATING THE RACHIS
EP2124777A4 (en) DEVICES FOR SPINE COLUMN TREATMENT
EP2079414A4 (en) SYSTEM FOR CHEMOHYPER THERMAL TREATMENT
EP2195067A4 (en) BONE TREATMENT UNIT
GB0606604D0 (en) Treatment apparatus
GB2445465B (en) Process for waste treatment
GB0714363D0 (en) Treatment apparatus
ZA200809528B (en) Treatment for depressive disorders
EP1986954A4 (en) SYSTEM FOR TREATING HYDROGEN SULFIDE
EP2083857A4 (en) METHOD FOR TREATING INTERFERENCE IN CONNECTION WITH MICA
TWI366224B (en) Substrate treatment apparatus
EP2219449A4 (en) METHOD FOR THE TREATMENT OF EXPOSURE TO DAMAGING
ZA200809527B (en) Treatment for depressive disorders
GB2444082B (en) Treatment apparatus for plant matter
HK1139856A1 (en) Methods for treating acute pain
GB2449996B (en) Effluent treatment process
EP2056850A4 (en) THERAPEUTIC METHODS FOR TREATING NEUROPATHIC PAIN
GB0718684D0 (en) Treatment method
PL2043792T3 (pl) System do obróbki ciągłej
EP2182884A4 (en) TREATMENT APPARATUS
PL2424514T3 (pl) Tapentadol do leczenia bólu w reumatoidalnym zapaleniu stawów
ZA200904478B (en) Novel therapeutic use for treating leukaemia
HK1225304A1 (zh) 治療骨癌
GB2454724B (en) Condensate treatment apparatus

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190421